GB1302169A - - Google Patents
Info
- Publication number
- GB1302169A GB1302169A GB5676170A GB5676170A GB1302169A GB 1302169 A GB1302169 A GB 1302169A GB 5676170 A GB5676170 A GB 5676170A GB 5676170 A GB5676170 A GB 5676170A GB 1302169 A GB1302169 A GB 1302169A
- Authority
- GB
- United Kingdom
- Prior art keywords
- oxyphenbutazone
- weight
- pharmaceutical compositions
- paracetamol
- dragúes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1302169 Pharmaceutical compositions containing paracetamol and oxyphenbutazone CIBA-GEIGY AG 30 Nov 1970 [1 Dec 1969] 56761/70 Heading A5B Pharmaceutical compositions having antiphlogistic, analgesic and antipyretic activity for the treatment of inflammatory diseases and conditions comprise from 1 to 5 parts by weight of paracetamol (p-hydroxyacetanilide) per part by weight of oxyphenbutazone (4-butyl-1-(phydroxyphenyl)-2-phenyl-3,5-pyrazolidinedione) in combination with a pharmaceutically acceptable diluent or carrier therefore. The compositions may be administered orally or rectally in the form of tablets, dragÚes, capsules or suppositories.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1788969 | 1969-12-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1302169A true GB1302169A (en) | 1973-01-04 |
Family
ID=4428855
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB5676170A Expired GB1302169A (en) | 1969-12-01 | 1970-11-30 |
Country Status (12)
Country | Link |
---|---|
BE (1) | BE759663A (en) |
CA (1) | CA946289A (en) |
DE (1) | DE2058893C3 (en) |
FR (1) | FR2073439B1 (en) |
GB (1) | GB1302169A (en) |
HK (1) | HK33476A (en) |
IE (1) | IE35205B1 (en) |
IL (1) | IL35752A (en) |
KE (1) | KE2619A (en) |
MY (1) | MY7600191A (en) |
NL (1) | NL7017179A (en) |
ZA (1) | ZA708098B (en) |
-
1970
- 1970-11-24 NL NL7017179A patent/NL7017179A/xx unknown
- 1970-11-30 BE BE759663D patent/BE759663A/en not_active IP Right Cessation
- 1970-11-30 ZA ZA708098*A patent/ZA708098B/en unknown
- 1970-11-30 DE DE2058893A patent/DE2058893C3/en not_active Expired
- 1970-11-30 IL IL35752A patent/IL35752A/en unknown
- 1970-11-30 GB GB5676170A patent/GB1302169A/en not_active Expired
- 1970-11-30 IE IE1528/70A patent/IE35205B1/en unknown
- 1970-11-30 CA CA099,411A patent/CA946289A/en not_active Expired
- 1970-11-30 FR FR707042912A patent/FR2073439B1/fr not_active Expired
-
1976
- 1976-04-27 KE KE2619*UA patent/KE2619A/en unknown
- 1976-06-03 HK HK334/76*UA patent/HK33476A/en unknown
- 1976-12-30 MY MY191/76A patent/MY7600191A/en unknown
Also Published As
Publication number | Publication date |
---|---|
IE35205L (en) | 1971-06-01 |
HK33476A (en) | 1976-06-11 |
BE759663A (en) | 1971-06-01 |
DE2058893C3 (en) | 1981-12-17 |
FR2073439B1 (en) | 1974-02-22 |
IL35752A (en) | 1973-07-30 |
DE2058893A1 (en) | 1971-06-09 |
ZA708098B (en) | 1971-08-25 |
DE2058893B2 (en) | 1981-02-26 |
IL35752A0 (en) | 1971-01-28 |
FR2073439A1 (en) | 1971-10-01 |
IE35205B1 (en) | 1975-12-10 |
NL7017179A (en) | 1971-06-03 |
KE2619A (en) | 1976-05-14 |
MY7600191A (en) | 1976-12-31 |
CA946289A (en) | 1974-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1204580A (en) | Pharmaceutical dosage forms | |
DE2963990D1 (en) | Analgesic tablet and process for its preparation | |
GB1458048A (en) | Pharmaceutical composition | |
GB1187348A (en) | New Amidoximes and process for the preparation thereof | |
GB1302169A (en) | ||
GB1202148A (en) | Pharmaceutical compositions | |
GB1049996A (en) | New medicine with anti-inflammatory and anti-rheumatic activity | |
GB1457546A (en) | Pharmaceutical preparations comprising cephalosporin derivatives | |
GB1281719A (en) | Anti-haemorrhoidally active preparations for local or rectal administration | |
GB1291559A (en) | N-(4-chlorocinnamoyl)-4-hydroxypiperidine | |
GB1126153A (en) | Novel polygalacturonic acid derivative | |
GB1125924A (en) | Organic bismuth derivative | |
GB1341376A (en) | Pharmaceutical compositions comprising 4-methyl-5-2-aminoethyl imidazole | |
GB1021070A (en) | A new triazolone and a process for its preparation | |
CA603690A (en) | Quinidine gluconate sustained medication tablet | |
GB1352392A (en) | Phenylisopropylamine derivatives | |
GB1217138A (en) | Pharmaceutical compositions based on derivatives of benzimidazole | |
GB1257264A (en) | ||
GB1375806A (en) | ||
GB1185335A (en) | A method for producing Protease | |
GB1191554A (en) | New Analgesic Composition. | |
GB1142757A (en) | Therapeutic compositions | |
GB1341484A (en) | Pharmaceutical compositions | |
GB1269616A (en) | Improvements in pharmaceutical compositions | |
GB1294538A (en) | Pharmaceutical compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed [section 19, patents act 1949] | ||
PCNP | Patent ceased through non-payment of renewal fee |